Revista Mexicana de Oftalmología

Register      Login

VOLUME 95 , ISSUE 1S ( January-February, 2021 ) > List of Articles

CARTA AL EDITOR

Impacto de diferir antiangiogénicos intravítreos en pacientes con edema macular diabético o secundario a obstrucción venosa central de la retina durante la pandemia de COVID-19

Jibran Mohamed-Noriega, Abraham Olvera-Barrios, Karim Mohamed-Noriega

Citation Information : Mohamed-Noriega J, Olvera-Barrios A, Mohamed-Noriega K. Impacto de diferir antiangiogénicos intravítreos en pacientes con edema macular diabético o secundario a obstrucción venosa central de la retina durante la pandemia de COVID-19. 2021; 95 (1S):44-45.

DOI: 10.24875/RMO.M20000135

License: CC BY-NC-ND 4.0

Published Online: 15-10-2020

Copyright Statement:  Copyright © 2018 Sociedad Mexicana de Oftalmología. Publicado por Permanyer.


Abstract

PDF Share
  1. Olivares-de Emparan JP, Garza-Leon M, García-Aguirre G, Azcárate-Coral T. Recomendaciones para el manejo de pacientes que requieren atención oftalmológica durante la pandemia de SARS-CoV-2 Recommendations for the management of patients that require eye care during the SARS-CoV-2 pandemic. Oftalm. 2020;94(3):103-12.
  2. Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117(6):1064-77.e35.
  3. Sun JK, Glassman AR, Beaulieu WT, Stockdale CR, Bressler NM, Flaxel C, et al. Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy. Ophthalmology. 2019;126(1):87-95.
  4. Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, et al. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010;117(6):1102-12.e1.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.